Lista de obras - François Vergez - Dominio Público Uruguay

A multicentric retrospective study of serum/plasma urea and creatinine concentrations in dogs using univariate and multivariate decision rules to evaluate diagnostic efficiency

artículo científico publicado en 2008

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia.

artículo científico publicado en 2015

Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations

artículo científico publicado en 2015

Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.

artículo científico publicado en 2017

Asymptomatic circulating T-cell clone cause renal polymorphic inflammatory fibrosis

artículo científico publicado en 2016

Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia.

artículo científico publicado en 2016

Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance.

artículo científico publicado en 2017

CD34+CD38-CD123+ Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents

scientific article published on 06 May 2020

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.

artículo científico publicado en 2015

Canine reference intervals for coagulation markers using the STA Satellite(R) and the STA-R Evolution(R) analyzers.

artículo científico publicado en 2010

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

artículo científico publicado en 2017

Class I phosphoinositide 3-kinases in normal and pathologic hematopoietic cells

artículo científico publicado en 2012

Comparison of plasma/serum urea and creatinine concentrations in the dog: a 5-year retrospective study in a commercial veterinary clinical pathology laboratory

artículo científico publicado en 2004

Dendrogenin A drives LXR to trigger lethal autophagy in cancers.

artículo científico publicado en 2017

Dexamethasone in hyperleukocytic acute myeloid leukemia

artículo científico publicado en 2018

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience.

artículo científico publicado en 2011

Eye-catching spindle-shaped mast cells without sinister significance

artículo científico publicado en 2020

High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.

artículo científico publicado en 2011

High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells

artículo científico publicado en 2017

Hyperferritinemia at diagnosis predicts relapse and overall survival in younger AML patients with intermediate-risk cytogenetics

artículo científico publicado en 2015

Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy

artículo científico publicado en 2015

Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia

scientific article published on 05 August 2013

Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia.

artículo científico publicado en 2016

Large granular lymphocytosis during quizartinib therapy

artículo científico publicado en 2020

Long noncoding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients

artículo científico publicado en 2017

Major rise of a chronic lymphoid leukemia clone during the course of COVID-19

artículo científico publicado en 2020

Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse-Bordeaux DATAML Registry Study

artículo científico publicado en 2020

Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia

artículo científico publicado en 2022

Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells.

artículo científico publicado en 2015

Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study

artículo científico publicado en 2020

Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas

artículo científico publicado en 2014

Signaling mechanisms that regulate ex vivo survival of human acute myeloid leukemia initiating cells.

artículo científico publicado en 2017

Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription.

artículo científico publicado en 2013

The ROS/SUMO axis contributes to the response of acute myeloid leukemia cells to chemotherapeutic drugs.

artículo científico publicado en 2014

The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors

artículo científico publicado en 2012

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies

artículo científico publicado en 2016

Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia.

artículo científico publicado en 2013

Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T-cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis

artículo científico publicado en 2014

Lista de obras de François Vergez

A multicentric retrospective study of serum/plasma urea and creatinine concentrations in dogs using univariate and multivariate decision rules to evaluate diagnostic efficiency

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia.

Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations

Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.

Asymptomatic circulating T-cell clone cause renal polymorphic inflammatory fibrosis

Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia.

Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance.

CD34+CD38-CD123+ Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.

Canine reference intervals for coagulation markers using the STA Satellite(R) and the STA-R Evolution(R) analyzers.

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

Class I phosphoinositide 3-kinases in normal and pathologic hematopoietic cells

Comparison of plasma/serum urea and creatinine concentrations in the dog: a 5-year retrospective study in a commercial veterinary clinical pathology laboratory

Dendrogenin A drives LXR to trigger lethal autophagy in cancers.

Dexamethasone in hyperleukocytic acute myeloid leukemia

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience.

Eye-catching spindle-shaped mast cells without sinister significance

High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.

High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells

Hyperferritinemia at diagnosis predicts relapse and overall survival in younger AML patients with intermediate-risk cytogenetics

Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy

Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia

Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia.

Large granular lymphocytosis during quizartinib therapy

Long noncoding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients

Major rise of a chronic lymphoid leukemia clone during the course of COVID-19

Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse-Bordeaux DATAML Registry Study

Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia

Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells.

Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study

Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas

Signaling mechanisms that regulate ex vivo survival of human acute myeloid leukemia initiating cells.

Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription.

The ROS/SUMO axis contributes to the response of acute myeloid leukemia cells to chemotherapeutic drugs.

The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies

Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia.

Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T-cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis